Patents by Inventor Brandon A. Lurie

Brandon A. Lurie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11911258
    Abstract: An occlusive device includes a covering component configured to modulate passage of blood or thrombus therethrough, and an occlusion frame that includes a plurality of elongate occlusion frame members. The elongate occlusion frame members are arranged to form a generally disc-shaped member. The occlusion frame is at least partially covered by the covering component. The device further includes an anchor frame that includes a plurality of elongate anchor frame members. The device further includes a first hub component from which the elongate frame members extend, and a second hub component from which the elongate frame members extend.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: February 27, 2024
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Charles J. Center, Edward H. Cully, Nathan L. Friedman, Cody L. Hartman, Nichlas L. Helder, Brandon A. Lurie, Steven J. Masters, Thomas R. McDaniel, Nathan K. Mooney, Aaron L. Paris, Roark N. Wolfe
  • Patent number: 11903826
    Abstract: Various features and associated advantages are described for diametrically adjustable support structures, adjustable valve structures, removable/replaceable valve structures, and associated systems and methods. Although some examples are directed toward prosthetic valve that is a conduit having a valve structure, or a “valved conduit” (e.g., used to replace a pulmonary valve and a portion of the corresponding pulmonary artery or an aortic valve and the aortic root), and other examples are directed toward prosthetic valves implanted native valve orifices (e.g., to replace an aortic or mitral valve), the features and advantages of the structures associated with those examples are interchangeable regardless of a particular application for which the examples are described.
    Type: Grant
    Filed: July 9, 2021
    Date of Patent: February 20, 2024
    Assignee: EDWARDS LIFESCIENCES CORPORATION
    Inventors: Kyle W. Colavito, Dustin V. Dienno, Paul D. Goodman, Brandon C. Hedberg, Brandon A. Lurie, Devin M. Nelson
  • Publication number: 20230389933
    Abstract: A device includes a plurality of elongate members, an occlusive component, and a support component. The occlusive component includes a plurality of first features each defined by a first portion of a respective elongate member. The support component includes a plurality of second features each defined by a second portion of the respective elongate member. A first termination element is defined by proximal end portions of the plurality of elongate members and located near a proximal end of the device, and a second termination element is defined by distal end portions of the plurality of elongate members and located near a distal end of the device. One or more anchor elements include a frame attachment portion and an anchor portion, the frame attachment portion including a first portion of a fixation elongate element wrapped around an elongate member, and the anchor portion including an anchor feature.
    Type: Application
    Filed: August 17, 2023
    Publication date: December 7, 2023
    Inventors: Coby C. Larsen, Brandon A. Lurie, Steven J. Masters, Thomas R. McDaniel, Stanislaw L. Zukowski
  • Publication number: 20230380821
    Abstract: A medical device for sealing a defect in a body includes a wire frame that includes a plurality of wires that form a first occluding member and a second occluding member, the wire frame including a defect-occupying portion disposed between the first occluding member and the second occluding member. The defect-occupying portion is adapted to fill a wide range of potential defect sizes, such that no more than five devices of a range of sizes are required to effectively seal a range of nominal defect sizes of approximately 8 to 35 mm.
    Type: Application
    Filed: August 9, 2023
    Publication date: November 30, 2023
    Inventors: Jacob A. Goble, Brandon A. Lurie, Steven J. Masters, Scot K. Mathena, Richard L. McClure
  • Patent number: 11771408
    Abstract: A medical device for sealing a defect in a body includes a wire frame that includes a plurality of wires that form a first occluding member and a second occluding member, the wire frame including a defect-occupying portion disposed between the first occluding member and the second occluding member. The defect-occupying portion is adapted to fill a wide range of potential defect sizes, such that no more than five devices of a range of sizes are required to effectively seal a range of nominal defect sizes of approximately 8 to 35 mm.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: October 3, 2023
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Jacob A. Goble, Brandon A. Lurie, Steven J. Masters, Scot K. Mathena, Richard L. McClure
  • Patent number: 11744594
    Abstract: A device includes a plurality of elongate members, an occlusive component, and a support component. The occlusive component includes a plurality of first features each defined by a first portion of a respective elongate member. The support component includes a plurality of second features each defined by a second portion of the respective elongate member. A first termination element is defined by proximal end portions of the plurality of elongate members and located near a proximal end of the device, and a second termination element is defined by distal end portions of the plurality of elongate members and located near a distal end of the device. One or more anchor elements include a frame attachment portion and an anchor portion, the frame attachment portion including a first portion of a fixation elongate element wrapped around an elongate member, and the anchor portion including an anchor feature.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: September 5, 2023
    Assignee: W.L. Gore & Associates, Inc.
    Inventors: Coby C. Larsen, Brandon A. Lurie, Steven J. Masters, Thomas R. McDaniel, Stanislaw L. Zukowski
  • Publication number: 20230093376
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Application
    Filed: November 23, 2022
    Publication date: March 23, 2023
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 11523919
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: December 13, 2022
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20220125567
    Abstract: An occlusive device includes a covering component configured to modulate passage of blood or thrombus therethrough, and an occlusion frame that includes a plurality of elongate occlusion frame members. The elongate occlusion frame members are arranged to form a generally disc-shaped member. The occlusion frame is at least partially covered by the covering component. The device further includes an anchor frame that includes a plurality of elongate anchor frame members. The device further includes a first hub component from which the elongate frame members extend, and a second hub component from which the elongate frame members extend.
    Type: Application
    Filed: January 7, 2022
    Publication date: April 28, 2022
    Inventors: Charles J. Center, Edward H. Cully, Nathan L. Friedman, Cody L. Hartman, Nichlas L. Helder, Brandon A. Lurie, Steven J. Masters, Thomas R. McDaniel, Nathan K. Mooney, Aaron L. Paris, Roark N. Wolfe
  • Publication number: 20210330457
    Abstract: Various features and associated advantages are described for diametrically adjustable support structures, adjustable valve structures, removable/replaceable valve structures, and associated systems and methods. Although some examples are directed toward prosthetic valve that is a conduit having a valve structure, or a “valved conduit” (e.g., used to replace a pulmonary valve and a portion of the corresponding pulmonary artery or an aortic valve and the aortic root), and other examples are directed toward prosthetic valves implanted native valve orifices (e.g., to replace an aortic or mitral valve), the features and advantages of the structures associated with those examples are interchangeable regardless of a particular application for which the examples are described.
    Type: Application
    Filed: July 9, 2021
    Publication date: October 28, 2021
    Inventors: Kyle W. Colavito, Dustin V. Dienno, Paul D. Goodman, Brandon C. Hedberg, Brandon A. Lurie, Devin M. Nelson
  • Patent number: 11071626
    Abstract: Various features and associated advantages are described for diametrically adjustable support structures, adjustable valve structures, removable/replaceable valve structures, and associated systems and methods. Although some examples are directed toward prosthetic valve that is a conduit having a valve structure, or a “valved conduit” (e.g., used to replace a pulmonary valve and a portion of the corresponding pulmonary artery or an aortic valve and the aortic root), and other examples are directed toward prosthetic valves implanted native valve orifices (e.g., to replace an aortic or mitral valve), the features and advantages of the structures associated with those examples are interchangeable regardless of a particular application for which the examples are described.
    Type: Grant
    Filed: March 15, 2019
    Date of Patent: July 27, 2021
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Kyle W. Colavito, Dustin V. Dienno, Paul D. Goodman, Brandon C. Hedberg, Brandon A. Lurie, Devin M. Nelson
  • Patent number: 10828019
    Abstract: A medical device for sealing a defect in a body includes a wire frame that includes a plurality of wires that form a first occluding member and a second occluding member, the wire frame including a defect-occupying portion disposed between the first occluding member and the second occluding member. The defect-occupying portion is adapted to fill a wide range of potential defect sizes, such that no more than five devices of a range of sizes are required to effectively seal a range of nominal defect sizes of approximately 8 to 35 mm.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: November 10, 2020
    Assignee: W.L. Gore & Associates, Inc.
    Inventors: Jacob A. Goble, Brandon A. Lurie, Steven J. Masters, Scot K. Mathena, Richard L. McClure
  • Publication number: 20200022828
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 23, 2020
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20190282360
    Abstract: Various features and associated advantages are described for diametrically adjustable support structures, adjustable valve structures, removable/replaceable valve structures, and associated systems and methods. Although some examples are directed toward prosthetic valve that is a conduit having a valve structure, or a “valved conduit” (e.g., used to replace a pulmonary valve and a portion of the corresponding pulmonary artery or an aortic valve and the aortic root), and other examples are directed toward prosthetic valves implanted native valve orifices (e.g., to replace an aortic or mitral valve), the features and advantages of the structures associated with those examples are interchangeable regardless of a particular application for which the examples are described.
    Type: Application
    Filed: March 15, 2019
    Publication date: September 19, 2019
    Inventors: Kyle W. Colavito, Dustin V. Dienno, Paul D. Goodman, Brandon C. Hedberg, Brandon A. Lurie, Devin M. Nelson
  • Publication number: 20190261966
    Abstract: A medical device for sealing a defect in a body includes a wire frame that includes a plurality of wires that form a first occluding member and a second occluding member, the wire frame including a defect-occupying portion disposed between the first occluding member and the second occluding member. The defect-occupying portion is adapted to fill a wide range of potential defect sizes, such that no more than five devices of a range of sizes are required to effectively seal a range of nominal defect sizes of approximately 8 to 35 mm.
    Type: Application
    Filed: May 7, 2019
    Publication date: August 29, 2019
    Inventors: Jacob A. Goble, Brandon A. Lurie, Steven J. Masters, Scot K. Mathena, Richard L. McClure
  • Patent number: 10335298
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: July 2, 2019
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Publication number: 20180153718
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Application
    Filed: November 22, 2017
    Publication date: June 7, 2018
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 9839540
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: December 12, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 9795496
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: October 24, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh
  • Patent number: 9737422
    Abstract: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: August 22, 2017
    Assignee: W. L. Gore & Associates, Inc.
    Inventors: Joseph R. Armstrong, Edward H. Cully, Michael W. Franklin, Mark Y. Hansen, Brandon A. Lurie, Craig R. McMurray, William D. Montgomery, Wendy J. Terry, Eric M. Tittelbaugh